Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.
Kevin T. Conroy net worth and biography

Kevin Conroy Biography and Net Worth

Kevin Conroy is the Chief Executive Officer, President, and Chairman of the Board of Exact Sciences. He became CEO 11 years ago and he has been part of a team that transformed Exact Sciences into one of the world’s premier cancer diagnostics companies with more than 4,500 employees.

Mr. Conroy has led Exact Sciences through the development, clinical trial, regulatory approval, and commercialization of its noninvasive colorectal cancer screening test, Cologuard®. This culminated with Cologuard becoming the first medical device or diagnostic to receive simultaneous FDA approval and national Medicare coverage. Since 2014, millions of Americans have used Cologuard to screen for colorectal cancer, the second leading cause of cancer death in the United States.

In 2019, Exact Sciences’ acquisition of Genomic Health, Inc., united two of the industry’s strongest brands, Cologuard and Oncotype DX®, and established the company’s position as the global leader in advanced cancer diagnostics. The global company is working to improve screening, early detection, and treatment guidance throughout the cancer continuum.

Before joining Exact Sciences, Mr. Conroy served as CEO and President of Third Wave Technologies, a molecular diagnostics company that developed a breakthrough cervical cancer screening test before being acquired by Hologic in 2008. Mr. Conroy also held leadership positions at GE Healthcare, a global leader in medical imaging and information technology, and practiced intellectual property law in private practice. Mr. Conroy currently serves as a director of Epizyme, Inc. and Adaptive Biotechnology Corporation.

Mr. Conroy is active in the Wisconsin community. He serves as a director of the Greater Madison Chamber of Commerce and on the University of Wisconsin-Madison Chancellor’s Advisory Council. He has also served as chair of The United Way of Dane County’s 2016 annual campaign and as a board member of Overture Center for the Arts.

A native of Flint, Michigan, Mr. Conroy holds a Bachelor of Science degree in electrical engineering from Michigan State University and earned his Juris Doctorate from the University of Michigan Law School.

What is Kevin T. Conroy's net worth?

The estimated net worth of Kevin T. Conroy is at least $53.72 million as of July 1st, 2022. Mr. Conroy owns 1,167,927 shares of Exact Sciences stock worth more than $53,724,642 as of December 2nd. This net worth estimate does not reflect any other investments that Mr. Conroy may own. Additionally, Mr. Conroy receives a salary of $2,370,000.00 as CEO at Exact Sciences. Learn More about Kevin T. Conroy's net worth.

How old is Kevin T. Conroy?

Mr. Conroy is currently 56 years old. There are 4 older executives and no younger executives at Exact Sciences. Learn More on Kevin T. Conroy's age.

What is Kevin T. Conroy's salary?

As the CEO of Exact Sciences Co., Mr. Conroy earned a total compensation package of $14,632,240.00 in 2021. Mr. Conroy earned a salary of $962,668.00, a bonus of $1,266,871.00, stock awards of $12,266,752.00, and other compensation of $135,949.00. Learn More on Kevin T. Conroy's salary.

How do I contact Kevin T. Conroy?

The corporate mailing address for Mr. Conroy and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at [email protected] Learn More on Kevin T. Conroy's contact information.

Has Kevin T. Conroy been buying or selling shares of Exact Sciences?

Kevin T. Conroy has not been actively trading shares of Exact Sciences during the past quarter. Most recently, Kevin T. Conroy sold 7 shares of the business's stock in a transaction on Friday, July 1st. The shares were sold at an average price of $40.75, for a transaction totalling $285.25. Following the completion of the sale, the chief executive officer now directly owns 1,167,927 shares of the company's stock, valued at $47,593,025.25. Learn More on Kevin T. Conroy's trading history.

Who are Exact Sciences' active insiders?

Exact Sciences' insider roster includes Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), James Doyle (Director), Jeffrey Elliott (CFO), Torsten Hoof (Insider), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.

Are insiders buying or selling shares of Exact Sciences?

In the last twelve months, insiders at the medical research company sold shares 17 times. They sold a total of 81,209 shares worth more than $5,224,397.85. The most recent insider tranaction occured on October, 12th when insider Everett Cunningham sold 16,872 shares worth more than $529,274.64. Insiders at Exact Sciences own 1.3 % of the company. Learn More about insider trades at Exact Sciences.

Information on this page was last updated on 10/12/2022.

Kevin T. Conroy Insider Trading History at Exact Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/1/2022Sell7$40.75$285.251,167,927View SEC Filing Icon  
3/1/2022Sell14,299$76.69$1,096,590.31View SEC Filing Icon  
2/23/2022Sell5,188$69.05$358,231.40View SEC Filing Icon  
2/15/2022Sell14,409$79.55$1,146,235.95View SEC Filing Icon  
11/1/2021Sell16,922$93.88$1,588,637.36View SEC Filing Icon  
10/1/2021Sell17,078$93.64$1,599,183.92View SEC Filing Icon  
5/3/2021Sell19,240$131.09$2,522,171.60776,736View SEC Filing Icon  
3/2/2021Sell9,796$138.42$1,355,962.32808,959View SEC Filing Icon  
2/24/2021Sell16,420$136.30$2,238,046.00826,785View SEC Filing Icon  
1/4/2021Sell31,814$128.74$4,095,734.36View SEC Filing Icon  
12/1/2020Sell30,577$124.56$3,808,671.12886,295View SEC Filing Icon  
11/2/2020Sell32,819$121.11$3,974,709.09916,521View SEC Filing Icon  
10/1/2020Sell27,425$103.55$2,839,858.75936,641View SEC Filing Icon  
9/1/2020Sell19,927$75.03$1,495,122.81View SEC Filing Icon  
2/27/2020Sell13,875$80.27$1,113,746.25986,701View SEC Filing Icon  
2/25/2020Sell18,115$85.11$1,541,767.65984,791View SEC Filing Icon  
3/11/2019Sell11,227$87.21$979,106.67949,753View SEC Filing Icon  
2/27/2019Sell9,169$95.07$871,696.83923,961View SEC Filing Icon  
1/25/2019Sell304,397$81.27$24,738,344.191,190,408View SEC Filing Icon  
11/12/2018Sell163,514$69.00$11,282,466.00886,011View SEC Filing Icon  
3/12/2018Sell11,459$52.19$598,045.21200,074View SEC Filing Icon  
2/26/2018Sell25,319$42.34$1,072,006.46211,183View SEC Filing Icon  
2/9/2018Sell101,488$45.72$4,640,031.36931,540View SEC Filing Icon  
1/23/2018Sell110,439$50.49$5,576,065.11940,491View SEC Filing Icon  
1/12/2018Sell125,402$52.79$6,619,971.58955,454View SEC Filing Icon  
12/22/2017Sell123,512$52.58$6,494,260.96953,564View SEC Filing Icon  
12/6/2017Sell121,849$53.45$6,512,829.05951,901View SEC Filing Icon  
11/21/2017Sell134,057$59.50$7,976,391.50View SEC Filing Icon  
11/9/2017Sell137,805$59.14$8,149,787.70967,867View SEC Filing Icon  
3/13/2017Sell12,059$21.16$255,168.44817,239View SEC Filing Icon  
11/15/2016Sell600,000$17.46$10,476,000.001,340,057View SEC Filing Icon  
3/1/2016Buy50,000$5.00$250,000.00687,907View SEC Filing Icon  
2/26/2016Sell6,895$5.81$40,059.95637,907View SEC Filing Icon  
2/23/2016Sell6,866$6.39$43,873.74632,168View SEC Filing Icon  
2/26/2015Sell8,425$23.44$197,482.00View SEC Filing Icon  
2/24/2015Sell9,798$22.90$224,374.20View SEC Filing Icon  
1/2/2015Sell9,484$26.72$253,412.48View SEC Filing Icon  
7/25/2014Sell11,336$15.99$181,262.64View SEC Filing Icon  
11/2/2012Buy2,000$9.13$18,260.00View SEC Filing Icon  
See Full Table

Kevin T. Conroy Buying and Selling Activity at Exact Sciences

This chart shows Kevin T Conroy's buying and selling at Exact Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Exact Sciences Company Overview

Exact Sciences logo
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Read More

Today's Range

Now: $46.00
Low: $44.78
High: $46.78

50 Day Range

MA: $37.06
Low: $30.35
High: $46.33

2 Week Range

Now: $46.00
Low: $29.27
High: $87.23


1,449,065 shs

Average Volume

2,164,074 shs

Market Capitalization

$8.17 billion

P/E Ratio


Dividend Yield



Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.